The S&P BSE Sensex closed at 26,190, up by 43 points and Nifty50 settled above 7,950 to end at 7,963, up by 17 points
An alumnus of IIM-A from the 1983 batch, Nanda was a Robert Braucher Professor of Practice at Harvard Law School and later a Harvard Business School faculty member, before he took charge on September 2, 2013.
Data also show that several other leading domestic pharma companies have recalled their products from the US
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months
And when an inspector asked about the contents of unlabelled vials in the laboratory glassware washing area, a plant worker dumped them down a sink and said the contents could not be determined, according to a July 18 letter from the US Food and Drug Administration to Wockhardt, which makes sterile injectable drugs and various forms of insulin.
The Nifty had hit its third successive record high of 7,922.70 today.
'Pfizer India has submitted an application on December 4 to the DCGI seeking emergency use authorization for its COVID-19 vaccine in India'
The health ID will contain information about medical data, prescriptions and diagnostic reports and summaries of previous discharge from hospitals for ailments. The mission is expected to bring efficiency and transparency in healthcare services in the country.
According to sources, around 10 crore doses of the Sputnik V vaccine is likely to be imported for emergency use in the country in the next six to seven months.
The ministry further stated that it was advisable to receive a complete schedule of the anti-coronavirus vaccine irrespective of past history of infection with COVID-19 as this will help in developing a strong immune response against the disease.
Metals, auto and banking shares were in the limelight in this session; the FMCG pack, however, ended lower.
BSE-200 companies's list shows that 96 companies had woman directors.
The remarks come amid suspected cases of COVID-19 reinfection being reported from abroad and from Indian states like Telangana, Karnataka, Gujarat, Punjab and Maharashtra.
A massive pan-India inoculation drive against COVID-19 was set in process on Tuesday with more than 56 lakh doses of the Covishield vaccine flown to 13 cities across India from Pune and taken to designated national and state-level stores amid tight security.
The procurement and distribution will be centralised though the government is yet to take a call on the initial number of doses that will be procured.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Armed with green nod and fund infusion, Gujarat govt getting ready to issue tenders to build infrastructure at the mega investment region
Only half India's population has received the first shot of Covishield and Covaxin and the government's immediate task is to first vaccinate its adult population before placing its focus on children.
The calculation excludes cross-holding of listed group cos in each other.
Markets in green tracking firm global cues.
India has purchased 500 million doses of the Oxford University-AstraZeneca vaccine candidate, one billion from the United States company Novavax and 100 million doses of the Sputnik V candidate from Russia's Gamaleya Research Institute, according to the US-based Duke University Global Health Innovation Center.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries:
Glimpses of the change Narendra Modi promised million of voters were visible at Rashtrapati Bhavan. Modi has now no excuse, but to perform and change India for the better. Sheela Bhatt/Rediff.com reports from the presidential palace. A feature on the swearing-in ceremony like none other.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries
Biggest contribution came from Bharti group-led Satya Electoral Trust.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
This is to take head on big American pharmaceutical giants, which in the recent past had launched a strong anti-India campaign against efforts of such companies to provide affordable health care not only to people in India, but also in the third world countries.
.jpg)
In a letter to health minister Harsh Vardhan, the Indian Pharmaceutical Alliance, an industry body representing leading pharma companies, including Sun Pharma, Lupin, Dr Reddy's Labs, Cadila Health and Glenmark, stressed the need for an out-of-court settlement with health activists fighting for the rights of clinical trial participants.
Ajit Mishra, vice president, Research, Religare Broking, answers your stock market queries.
In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.
A glance back at some of the important ups and down Indian Inc faced in 2018.
Import alert on Ranbaxy's Mohali unit; Strides' injectible arm gets warning letter
